Developer docs
API playgroundTry for free, no card

Search company profiles

ITC Farma

Full company profile

uuid002l1pl

Namestring
ITC Farma
Legal namestring
ITC FARMA Srl
Websiteurl
itcfarma.it
Company typeenum
Private
Founded yearint
1960
Descriptiontext

ITC Farma Srl is an Italian pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Pomezia, south of Rome, within one of Italy's principal pharmaceutical clusters. Founded in the 1960s and operating as a privately held company since a 1996 management buyout from the Fisons Plc Group, ITC Farma runs a 12,000 sqm facility producing solid and liquid oral dosage forms (tablets, hard capsules, oral suspensions, solutions, drops, nasal sprays, sterilized inhalation liquids) plus food supplements, and is authorized to handle hormonal substances. The company is EU-GMP Volume 10 certified, AIFA-authorized for clinical trial (IMP) production, and Ministry-of-Health-authorized for food supplement packaging in a dedicated segregated area.

ITC Farma generates revenue through a portfolio of B2B services: full-cost turn-key contract manufacturing, intermediate supply of tablets and capsules, primary and secondary packaging, clinical trial (IMP) batch production, worldwide storage and distribution of medicinal products, vaccines and dietary supplements, and quality assurance/control services supported by a 250 sqm QC laboratory performing chemical, physical, and microbiological analysis under ICH guidelines. Its primary customer segments are pharmaceutical multinationals producing branded and generic medicines, Italian domestic pharmaceutical companies, food supplement manufacturers, and CROs/sponsors of clinical trials. Pricing is negotiated per project and is not publicly disclosed.

Technically, the facility runs an advanced equipment stack sourced primarily through a strategic partnership with IMA Active: the PREXIMA 300 high-speed tablet press (2.5 million micro-tablets per hour, 2018 Pharma Innovation Awards winner), ARIA 900 fluid bed system, ADAPTA 100 flexible capsule filler, GS 600 coating machine, and a 240-blister-per-minute packaging line with continuous printing, tamper-evident technology, and DataMatrix-based serialization for EU Falsified Medicines Directive compliance. A 2019 R&D laboratory and the €2.77M FESR-funded NU.C.FAR.NA/LIFE 2020 pilot granulation plant (built with Sapienza University of Rome) support process and method transfer. The company employs 51–100 people, invests in Lean manufacturing, and pursues regulated horizontal expansion into the nutraceutical vertical (announced 2022).

Short descriptiontext

ITC Farma is an Italian privately held CDMO in Pomezia that contract-manufactures solid and liquid oral pharmaceuticals, clinical trial (IMP) batches, and food supplements for pharmaceutical multinationals, Italian pharma companies, and nutraceutical brands under EU-GMP and AIFA authorization.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPomezia, Italy
HQ citystring
Pomezia
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract manufacturing, CDMO services, clinical trial production, oral solid dosage manufacturing, pharmaceutical packaging services
Industry1 code
PRIMARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Pharmaceutical Contract Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model6 records
1Contract Manufacturing - Full Cost (Turn-key)
TypeProfessional Services
Description

Complete pharmaceutical product manufacturing from raw materials to finished product, including all production steps and quality control. Full responsibility for the entire production process on behalf of clients.

itcfarma.it
2Intermediate Products Supply
TypeOne Time License
Description

Supply of stepping stones in the process such as tablets or capsules to pharmaceutical companies that complete manufacturing in-house.

itcfarma.it
3Primary and Secondary Packaging
TypeProfessional Services
Description

Packaging services for pharmaceutical products including both primary packaging (blistering, bottling) and secondary packaging (cartoning, labeling).

itcfarma.it
4Food Supplements Secondary Packaging
TypeProfessional Services
Description

Secondary packaging of food supplements and dietary supplements, processed in dedicated and isolated areas authorized by the Ministry of Health.

itcfarma.it
5Clinical Trial Products (IMP)
TypeProfessional Services
Description

Production of pilot batches for clinical trials authorized by Regulatory Agencies, including granules, effervescent granules, and specialized liquids. AIFA authorized.

itcfarma.it
6Storage and Distribution
TypeManaged Services
Description

Warehouse and distribution services for medicinal products (human and veterinary), vaccines, and dietary supplements worldwide.

itcfarma.it
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ITC Farma is an Italian pharmaceutical contract manufacturer (CDMO) that produces solid and liquid oral pharmaceutical products, clinical trial materials (IMP), and packaged food supplements on behalf of pharmaceutical multinationals, Italian pharmaceutical companies, and clinical trial sponsors. The company also provides primary and secondary packaging, quality assurance, quality control laboratory services, and worldwide storage and distribution of medicinal products, vaccines, and dietary supplements under EU-GMP Volume 10 and AIFA authorization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Production capacity of over 10 million packages per year
+5 more records
Product overview1 text field

ITC Farma is an Italian pharmaceutical company specializing in contract manufacturing (CDMO) for the Italian and multinational market. The portfolio includes Pharma Production for solid and liquid oral drugs, Food Supplements Production, and Clinical Trials (IMP) production. Supporting services include Storage and Distribution, Quality Assurance, and a Quality Control Laboratory. The company operates with EU-GMP Volume 10 standards, AIFA authorization for clinical trials, and Ministry of Health authorization. Production capabilities include tablets (film-coated, non-film-coated, chewable), hard capsules, oral suspensions, solutions, drops, nasal sprays, and inhalation liquids. The company has invested in advanced manufacturing equipment including PREXIMA 300 tablet press (Pharma Innovation Awards 2018), ARIA 900 fluid bed technology, ADAPTA 100 capsule filler, and blister packaging machines with 240 blisters/min capacity, achieving over 30 million packages annually.

Product and service6 records
1Pharma Production (Contract Manufacturing)
CategoryContract Manufacturing
Description

Full-service pharmaceutical contract manufacturing including full-cost turn-key production, intermediate supply of tablets or capsules, and primary and secondary packaging for brand and generic medicines. Serves pharmaceutical multinationals and Italian pharmaceutical companies with EU-GMP Volume 10 compliance.

2Food Supplements Production
CategoryContract Manufacturing
Description

Secondary packaging of food supplements and dietary supplements performed in a dedicated and fully segregated area from pharmaceutical production, authorized by the Ministry of Health. Capable of processing 800 kg of powders per working day.

3Clinical Trials Production (IMP)
CategoryContract Manufacturing
Description

Production of pilot batches of Investigational Medicinal Products (IMP) for clinical trials, including granules, effervescent granules, and specialized liquids (including hormonal substances). AIFA-authorized for clinical study material production.

4Storage and Distribution
CategoryLogistics Services
Description

Worldwide storage and distribution services for medicinal products (human and veterinary), vaccines, and dietary supplements, supporting clients' global supply chain needs.

5Quality Assurance
CategoryQuality Services
Description

Quality assurance services covering qualification of API and excipient producers, packaging material producers and warehouse suppliers, drafting of quality agreements, process validation protocols, and Product Quality Reviews (PQR).

6Quality Control Laboratory
CategoryQuality Services
Description

250 sqm quality control laboratory performing chemical, physical, and microbiological analyses (including Class A sterility tests), development and validation of analytical methods, and ICH-compliant stability studies.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1IMA Active
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2016-09-01
Description

Long-standing equipment partnership with IMA Active, a leading manufacturer of pharmaceutical machinery. ITC Farma has acquired multiple pieces of equipment including PREXIMA 300 tablet press (Pharma Innovation Awards 2018 winner), ARIA 900 fluid bed technology, ADAPTA 100 capsule filler, GS 600 coating machine, MYLAB, ROTO CUBE 12, and ROTO MIX 1200. The partnership includes comprehensive technical support, process optimization assistance, and ongoing collaboration for pharmaceutical production excellence. IMA provides process experts who work alongside ITC Farma's internal technologists for continuous improvement.

itcfarma.it
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Eurofins' contract development and manufacturing arm, offering API development, solid dose manufacturing and analytical services. Comparable as a contract pharmaceutical manufacturer with GMP-certified oral solid dose capabilities and integrated analytical/QC laboratory services similar to ITC Farma's QC lab offering.

TypeDirect peer
Description

European CDMO (owned by ICIG) offering oral solid dose, sterile injectables, peptides and high-potency manufacturing. Comparable as a European contract manufacturer offering GMP-compliant solid and liquid pharmaceutical production, packaging and clinical trial material supply.

3Fareva
TypeDirect peer
Description

Privately-held French CDMO providing contract development and manufacturing for pharmaceuticals, cosmetics and APIs. Comparable as a privately-owned European CDMO focused on solid/liquid oral dose manufacturing and packaging services for multinational clients.

4Recipharm
TypeDirect peer
Description

Swedish-headquartered European CDMO specializing in oral solid dose, sterile filling and biologics with multiple manufacturing sites. Directly comparable as a mid-sized European CDMO offering contract manufacturing for branded and generic pharmaceuticals, with similar customer segments among Big Pharma clients.

TypeDirect peer
Description

Spanish CDMO specialized in oral solid dose development and manufacturing (including high-potency and oncology). Comparable as a mid-sized European CDMO focused on solid oral dosage forms with GMP certification and contract manufacturing services.

TypeBroad incumbent
Description

Swiss-listed global CDMO providing contract development and manufacturing across APIs, biologics, cell and gene therapies, and oral dosage forms. Comparable at a category level as a top-tier global CDMO with EU-GMP certified oral solid dose capabilities, but operates at far greater scale with much broader portfolio and global footprint.

TypeDirect peer
Description

Swiss-listed CDMO providing API and oral solid dose contract manufacturing, with global GMP-certified sites. Comparable mid-to-large CDMO with similar focus on contract manufacturing of finished oral pharmaceuticals for Big Pharma clients.

TypeBroad incumbent
Description

U.S.-headquartered global CDMO providing advanced drug delivery, oral solid dose, biologics and clinical supply services across multiple continents. Comparable at a category level as a leading global CDMO offering oral solid dose contract manufacturing, but operates at vastly greater scale, with broader geographic footprint and portfolio.

TypeDirect peer
Description

German-headquartered European CDMO with broad capabilities in oral solid dose, sterile liquids and semi-solids. Comparable mid-sized contract manufacturer serving similar Big Pharma customers with EU-GMP certified facilities for solid/liquid oral pharmaceuticals.

TypeDirect peer
Description

Italian CDMO based in Latina (southern Lazio region, near Rome) specializing in GMP contract manufacturing including sterile injectables and biological products. Comparable as an Italian-headquartered CDMO serving pharmaceutical multinationals from a single-cluster location with EU-GMP authorization.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ITC Farma

Pharmaceutical Contract Manufacturingitcfarma.it

ITC Farma is an Italian privately held CDMO in Pomezia that contract-manufactures solid and liquid oral pharmaceuticals, clinical trial (IMP) batches, and food supplements for pharmaceutical multinationals, Italian pharma companies, and nutraceutical brands under EU-GMP and AIFA authorization.

What ITC Farma does

ITC Farma Srl is an Italian pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Pomezia, south of Rome, within one of Italy's principal pharmaceutical clusters. Founded in the 1960s and operating as a privately held company since a 1996 management buyout from the Fisons Plc Group, ITC Farma runs a 12,000 sqm facility producing solid and liquid oral dosage forms (tablets, hard capsules, oral suspensions, solutions, drops, nasal sprays, sterilized inhalation liquids) plus food supplements, and is authorized to handle hormonal substances. The company is EU-GMP Volume 10 certified, AIFA-authorized for clinical trial (IMP) production, and Ministry-of-Health-authorized for food supplement packaging in a dedicated segregated area.

ITC Farma generates revenue through a portfolio of B2B services: full-cost turn-key contract manufacturing, intermediate supply of tablets and capsules, primary and secondary packaging, clinical trial (IMP) batch production, worldwide storage and distribution of medicinal products, vaccines and dietary supplements, and quality assurance/control services supported by a 250 sqm QC laboratory performing chemical, physical, and microbiological analysis under ICH guidelines. Its primary customer segments are pharmaceutical multinationals producing branded and generic medicines, Italian domestic pharmaceutical companies, food supplement manufacturers, and CROs/sponsors of clinical trials. Pricing is negotiated per project and is not publicly disclosed.

Technically, the facility runs an advanced equipment stack sourced primarily through a strategic partnership with IMA Active: the PREXIMA 300 high-speed tablet press (2.5 million micro-tablets per hour, 2018 Pharma Innovation Awards winner), ARIA 900 fluid bed system, ADAPTA 100 flexible capsule filler, GS 600 coating machine, and a 240-blister-per-minute packaging line with continuous printing, tamper-evident technology, and DataMatrix-based serialization for EU Falsified Medicines Directive compliance. A 2019 R&D laboratory and the €2.77M FESR-funded NU.C.FAR.NA/LIFE 2020 pilot granulation plant (built with Sapienza University of Rome) support process and method transfer. The company employs 51–100 people, invests in Lean manufacturing, and pursues regulated horizontal expansion into the nutraceutical vertical (announced 2022).

ITC Farma firmographics

Firmographics
Name
ITC Farma
Legal name
ITC FARMA Srl
Website
https://itcfarma.it
Company type
Private
Founded year
1960
Operating status
Operating
Headcount range
51–100 employees
Short description
ITC Farma is an Italian privately held CDMO in Pomezia that contract-manufactures solid and liquid oral pharmaceuticals, clinical trial (IMP) batches, and food supplements for pharmaceutical multinationals, Italian pharma companies, and nutraceutical brands under EU-GMP and AIFA authorization.
Ownership category
akta.pro rank

ITC Farma industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Pharmaceutical contract manufacturing
  • CDMO services
  • Clinical trial production
  • Oral solid dosage manufacturing
  • Pharmaceutical packaging services

Where ITC Farma is headquartered

Location

Headquarters

HQ city
Pomezia
HQ country
Italy
HQ region
Europe

Offices2 records

Markets served

ITC Farma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Contract Manufacturing - Full Cost (Turn-key): Complete pharmaceutical product manufacturing from raw materials to finished product, including all production steps and quality control. Full responsibility for the entire production process on behalf of clients.
  2. Intermediate Products Supply: Supply of stepping stones in the process such as tablets or capsules to pharmaceutical companies that complete manufacturing in-house.
  3. Primary and Secondary Packaging: Packaging services for pharmaceutical products including both primary packaging (blistering, bottling) and secondary packaging (cartoning, labeling).
  4. Food Supplements Secondary Packaging: Secondary packaging of food supplements and dietary supplements, processed in dedicated and isolated areas authorized by the Ministry of Health.
  5. Clinical Trial Products (IMP): Production of pilot batches for clinical trials authorized by Regulatory Agencies, including granules, effervescent granules, and specialized liquids. AIFA authorized.
  6. Storage and Distribution: Warehouse and distribution services for medicinal products (human and veterinary), vaccines, and dietary supplements worldwide.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

ITC Farma product offering

Product offering

Core offering

ITC Farma is an Italian pharmaceutical contract manufacturer (CDMO) that produces solid and liquid oral pharmaceutical products, clinical trial materials (IMP), and packaged food supplements on behalf of pharmaceutical multinationals, Italian pharmaceutical companies, and clinical trial sponsors. The company also provides primary and secondary packaging, quality assurance, quality control laboratory services, and worldwide storage and distribution of medicinal products, vaccines, and dietary supplements under EU-GMP Volume 10 and AIFA authorization.

Product overview

ITC Farma is an Italian pharmaceutical company specializing in contract manufacturing (CDMO) for the Italian and multinational market. The portfolio includes Pharma Production for solid and liquid oral drugs, Food Supplements Production, and Clinical Trials (IMP) production. Supporting services include Storage and Distribution, Quality Assurance, and a Quality Control Laboratory. The company operates with EU-GMP Volume 10 standards, AIFA authorization for clinical trials, and Ministry of Health authorization. Production capabilities include tablets (film-coated, non-film-coated, chewable), hard capsules, oral suspensions, solutions, drops, nasal sprays, and inhalation liquids. The company has invested in advanced manufacturing equipment including PREXIMA 300 tablet press (Pharma Innovation Awards 2018), ARIA 900 fluid bed technology, ADAPTA 100 capsule filler, and blister packaging machines with 240 blisters/min capacity, achieving over 30 million packages annually.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharma Production (Contract Manufacturing) Full-service pharmaceutical contract manufacturing including full-cost turn-key production, intermediate supply of tablets or capsules, and primary and secondary packaging for brand and generic medicines. Serves pharmaceutical multinationals and Italian pharmaceutical companies with EU-GMP Volume 10 compliance.
  • Food Supplements Production Secondary packaging of food supplements and dietary supplements performed in a dedicated and fully segregated area from pharmaceutical production, authorized by the Ministry of Health. Capable of processing 800 kg of powders per working day.
  • Clinical Trials Production (IMP) Production of pilot batches of Investigational Medicinal Products (IMP) for clinical trials, including granules, effervescent granules, and specialized liquids (including hormonal substances). AIFA-authorized for clinical study material production.
  • Storage and Distribution Worldwide storage and distribution services for medicinal products (human and veterinary), vaccines, and dietary supplements, supporting clients' global supply chain needs.
  • Quality Assurance Quality assurance services covering qualification of API and excipient producers, packaging material producers and warehouse suppliers, drafting of quality agreements, process validation protocols, and Product Quality Reviews (PQR).
  • Quality Control Laboratory 250 sqm quality control laboratory performing chemical, physical, and microbiological analyses (including Class A sterility tests), development and validation of analytical methods, and ICH-compliant stability studies.

Quantifiable outcome

  • Production capacity of over 10 million packages per year
  • +5 more outcomes

Companies that use ITC Farma

Customer profile

Segments4 records

Ideal customer profiles4 records

ITC Farma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

ITC Farma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • IMA ActivecoreTechnology or Integration · 1 September 2016Long-standing equipment partnership with IMA Active, a leading manufacturer of pharmaceutical machinery. ITC Farma has acquired multiple pieces of equipment including PREXIMA 300 tablet press (Pharma Innovation Awards 2018 winner), ARIA 900 fluid bed technology, ADAPTA 100 capsule filler, GS 600 coating machine, MYLAB, ROTO CUBE 12, and ROTO MIX 1200. The partnership includes comprehensive technical support, process optimization assistance, and ongoing collaboration for pharmaceutical production excellence. IMA provides process experts who work alongside ITC Farma's internal technologists for continuous improvement.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

ITC Farma competitors and assessment

Company assessment

Emerging players

  • Eurofins CDMO: Eurofins' contract development and manufacturing arm, offering API development, solid dose manufacturing and analytical services. Comparable as a contract pharmaceutical manufacturer with GMP-certified oral solid dose capabilities and integrated analytical/QC laboratory services similar to ITC Farma's QC lab offering.

Direct peers

  • CordenPharma International: European CDMO (owned by ICIG) offering oral solid dose, sterile injectables, peptides and high-potency manufacturing. Comparable as a European contract manufacturer offering GMP-compliant solid and liquid pharmaceutical production, packaging and clinical trial material supply.
  • Fareva: Privately-held French CDMO providing contract development and manufacturing for pharmaceuticals, cosmetics and APIs. Comparable as a privately-owned European CDMO focused on solid/liquid oral dose manufacturing and packaging services for multinational clients.
  • Recipharm: Swedish-headquartered European CDMO specializing in oral solid dose, sterile filling and biologics with multiple manufacturing sites. Directly comparable as a mid-sized European CDMO offering contract manufacturing for branded and generic pharmaceuticals, with similar customer segments among Big Pharma clients.
  • Idifarma Pharmaceutical Development: Spanish CDMO specialized in oral solid dose development and manufacturing (including high-potency and oncology). Comparable as a mid-sized European CDMO focused on solid oral dosage forms with GMP certification and contract manufacturing services.
  • Siegfried Holding: Swiss-listed CDMO providing API and oral solid dose contract manufacturing, with global GMP-certified sites. Comparable mid-to-large CDMO with similar focus on contract manufacturing of finished oral pharmaceuticals for Big Pharma clients.
  • Aenova Holding: German-headquartered European CDMO with broad capabilities in oral solid dose, sterile liquids and semi-solids. Comparable mid-sized contract manufacturer serving similar Big Pharma customers with EU-GMP certified facilities for solid/liquid oral pharmaceuticals.
  • BSP Pharmaceuticals: Italian CDMO based in Latina (southern Lazio region, near Rome) specializing in GMP contract manufacturing including sterile injectables and biological products. Comparable as an Italian-headquartered CDMO serving pharmaceutical multinationals from a single-cluster location with EU-GMP authorization.

Broad incumbents

  • Lonza Group: Swiss-listed global CDMO providing contract development and manufacturing across APIs, biologics, cell and gene therapies, and oral dosage forms. Comparable at a category level as a top-tier global CDMO with EU-GMP certified oral solid dose capabilities, but operates at far greater scale with much broader portfolio and global footprint.
  • Catalent: U.S.-headquartered global CDMO providing advanced drug delivery, oral solid dose, biologics and clinical supply services across multiple continents. Comparable at a category level as a leading global CDMO offering oral solid dose contract manufacturing, but operates at vastly greater scale, with broader geographic footprint and portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

ITC Farma social profiles

Digital presence

ITC Farma compliance and trust

Trust signal

Compliance3 records

ITC Farma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ITC Farma leadership team

Management profile

Number of profiles

Profiles8 records

ITC Farma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ITC Farma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ITC Farma

What does ITC Farma do?

ITC Farma is an Italian pharmaceutical contract manufacturer (CDMO) that produces solid and liquid oral pharmaceutical products, clinical trial materials (IMP), and packaged food supplements on behalf of pharmaceutical multinationals, Italian pharmaceutical companies, and clinical trial sponsors. The company also provides primary and secondary packaging, quality assurance, quality control laboratory services, and worldwide storage and distribution of medicinal products, vaccines, and dietary supplements under EU-GMP Volume 10 and AIFA authorization.

Is ITC Farma a public or private company?

ITC Farma is a private company. It is classified as private equity controlled and is currently operating.

When was ITC Farma founded?

ITC Farma was founded in 1960. It employs 51 to 100 people.

Where is ITC Farma based?

ITC Farma is headquartered in Pomezia, Italy, in the Europe region.

How does ITC Farma make money?

Six revenue lines are on record. Contract Manufacturing - Full Cost (Turn-key) is the primary driver. The others are intermediate Products Supply, primary and Secondary Packaging, food Supplements Secondary Packaging, clinical Trial Products (IMP) and storage and Distribution.

Who are ITC Farma's main competitors?

Eurofins CDMO is listed as an emerging player. Direct peers are CordenPharma International, Fareva, Recipharm, Idifarma Pharmaceutical Development, Siegfried Holding, Aenova Holding and BSP Pharmaceuticals. Broad incumbents are Lonza Group and Catalent.

Does ITC Farma have an API?

No public API is recorded for ITC Farma.

What industry is ITC Farma in?

ITC Farma's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales